SCHEMBL7738722

SCHEMBL7738722

CCCCCNC(=O)c1c[nH]c2ccc(OCC)cc2c1=O

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.81
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
POLB P06746 2/20 0.69
MAPT P10636 5/20 0.69
LMNA P02545 3/20 0.69
ALDH1A1 P00352 3/20 0.69
HPGD P15428 3/20 0.69
TP53 P04637 2/20 0.69
HSD17B10 Q99714 4/20 0.63
HTT P42858 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
USP2 O75604 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
GAA P10253 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7740429 0.92 KDM4E (0.78) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL6204017 0.90 KDM4E (0.86) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL6204734 0.89 KDM4E (1.00) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL6204768 0.87 KDM4E (0.80) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL18038659 0.84 MAPT (0.93) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL7738707 0.83 POLB (0.70) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL6204810 0.83 POLB (0.88) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL6204972 0.82 POLB (1.00) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL3816203 0.81 KDM4E (0.55) KDM4EMEN1KMT2APOLBMAPT
SCHEMBL13649612 0.81 KDM4E (0.55) KDM4EMEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed